<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35251701</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2058-4601</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>11</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Acta radiologica open</Title>
          <ISOAbbreviation>Acta Radiol Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Subclinical involvement of the trunk muscles in idiopathic inflammatory myopathies.</ArticleTitle>
        <Pagination>
          <StartPage>20584601221075796</StartPage>
          <MedlinePgn>20584601221075796</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">20584601221075796</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/20584601221075796</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whole-body magnetic resonance imaging (WB-MRI) is a useful tool for revealing the disease-specific distribution of affected muscles and clinically asymptomatic muscle involvements in idiopathic inflammatory myopathies (IIMs).</AbstractText>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To examine inflammatory changes in the systemic skeletal muscles, including the thoracoabdominal trunk, in IIMs using WB-MRI.</AbstractText>
          <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">We prospectively obtained WB-MRI axial images from 10 patients with IIMs, including antisynthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM), sporadic inclusion body myositis, and myopathy associated with antimitochondrial antibody. We evaluated 108 systemic skeletal muscles in short-tau inversion recovery (STIR) images and rated changes in signal intensity using a semiquantitative scale. Correlations between STIR sum score, peak creatine kinase (CK) and muscle strength were examined. We also investigated the correlation between STIR sum score within the thoracoabdominal trunk and forced vital capacity.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">High STIR signal changes were frequently identified in asymptomatic and routinely unexamined muscles. Thoracoabdominal trunk muscles were frequently involved in ASS and IMNM. Peak CK was positively correlated with the STIR sum score (<i>R</i> <sup>2</sup> = 0.62, <i>p</i> &lt; .01). There was no significant correlation between the STIR sum score within the thoracoabdominal trunk and forced vital capacity.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">WB-MRI can detect subclinical muscle inflammation in the systemic muscles including the trunk muscles. STIR sum score is positively correlated with serum peak CK level; therefore, it could be a biomarker of overall muscle inflammation.</AbstractText>
          <CopyrightInformation>© The Author(s) 2022.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Matsuda</LastName>
            <ForeName>Nozomu</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0003-3773-6778</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kobayashi</LastName>
            <ForeName>Shunsuke</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hasegawa</LastName>
            <ForeName>Osamu</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Nuclear Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yoshida</LastName>
            <ForeName>Kenji</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kubo</LastName>
            <ForeName>Hitoshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ugawa</LastName>
            <ForeName>Yoshikazu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Neurophysiology, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanai</LastName>
            <ForeName>Kazuaki</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Fukushima Medical University, Fukushima, Japan.</Affiliation>
              <Identifier Source="RINGGOLD">12775</Identifier>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Acta Radiol Open</MedlineTA>
        <NlmUniqueID>101651010</NlmUniqueID>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Whole-body MRI</Keyword>
        <Keyword MajorTopicYN="N">idiopathic inflammatory myopathy</Keyword>
        <Keyword MajorTopicYN="N">muscle MRI</Keyword>
        <Keyword MajorTopicYN="N">short-tau inversion recovery image</Keyword>
        <Keyword MajorTopicYN="N">trunk muscle</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>5</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35251701</ArticleId>
        <ArticleId IdType="pmc">PMC8891869</ArticleId>
        <ArticleId IdType="doi">10.1177/20584601221075796</ArticleId>
        <ArticleId IdType="pii">10.1177_20584601221075796</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Dalakas MC. Inflammatory muscle diseases. N Engl J Med
2015; 372: 1734–1747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25923553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, et al.
Classification and management of adult inflammatory myopathies. Lancet Neurol
2018; 17: 816–828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30129477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noguchi E, Uruha A, Suzuki S, et al.
Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol
2017; 74: 992–999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5710328</ArticleId>
            <ArticleId IdType="pubmed">28586844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe Y, Uruha A, Suzuki S, et al.
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry
2016; 87: 1038–1044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27147697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, et al.
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis
2017; 76: 681–687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6019551</ArticleId>
            <ArticleId IdType="pubmed">27651398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barsotti S, Zampa V, Talarico R, et al.
Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center. Muscle Nerve
2016; 54: 666–672.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27279002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wattjes MP, Fischer D. Neuromuscular Imaging. 1st ed. New York, NY: Springer-Verlag, 2013.</Citation>
        </Reference>
        <Reference>
          <Citation>O’Connell MJ, Powell T, Brennan D, et al.
Whole-body MR imaging in the diagnosis of polymyositis. Am J Roentgenol
2002; 179: 967–971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12239048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karino K, Kono M, Kono M, et al.
Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis. Rheumatology (Oxford)
2020; 59: 1734–1742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31925431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoogendijk JE, Amato AA, Lecky BR, et al.
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord
2004; 14: 337–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15099594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Griggs RC, Askanas V, DiMauro S, et al.
Inclusion body myositis and myopathies. Ann Neurol
1995; 38: 705–713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7486861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain
2012; 135: 1767–1777.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22561642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuda N, Sato S, Nemoto A, et al.
Thoracoabdominal muscle involvement in anti-PL-7 myopathy revealed by whole-body magnetic resonance imaging. Rinsho Shinkeigaku
2018; 58: 692–695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30369527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Brien M. Aids to the Examination of the Peripheral Nervous System. 5th ed. London: Elsevier Health Sciences, 2010.</Citation>
        </Reference>
        <Reference>
          <Citation>Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve
1991; 14: 1103–1109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1745285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mercuri E, Pichiecchio A, Allsop J, et al.
Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging
2007; 25: 433–440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17260395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poliachik SL, Friedman SD, Carter GT, et al.
Skeletal muscle edema in muscular dystrophy: clinical and diagnostic implications. Phys Med Rehabil Clin N Am
2012; 23: 107–122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22239878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas
1960; 20: 37–46.</Citation>
        </Reference>
        <Reference>
          <Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics
1977; 33: 159–174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">843571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Filli L, Winklhofer S, Andreisek G, et al.
Imaging of myopathies. Radiol Clin North Am
2017; 55: 1055–1070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28774448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malattia C, Damasio MB, Madeo A, et al.
Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis
2014; 73: 1083–1089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23636654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uenaka T, Kowa H, Ohtsuka Y, et al.
Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies. Eur Neurol
2017; 78: 290–295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29049993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uenaka T, Kowa H, Sekiguchi K, et al.
Myositis with antimitochondrial antibodies diagnosed by rectus abdominis muscle biopsy. Muscle Nerve
2013; 47: 766–768.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23553600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day JA, Bajic N, Gentili S, et al.
Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies. Muscle Nerve
2019; 60: 549–557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31397909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebbo M, Chagnaud C, Figarella-Branger D, et al.
Antisynthethase syndrome presenting as peripheral limb fasciitis. Joint Bone Spine
2013; 80: 528–530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23618805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cox FM, Reijnierse M, van Rijswijk CSP, et al.
Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology (Oxford)
2011; 50: 1153–1161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21288962</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
